Amos Olalekan Abolaji

Amos Olalekan Abolaji

Auto-generated profile, based on publicly available information

Amos Olalekan Abolaji


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Journal of Trace Elements in Medicine and Biology
Verified
Journal Article
Open access
KFKehinde D. Fasae
Kehinde D. Fasae
AAAmos O. Abolaji
Amos O. Abolaji
TFTolulope R. Faloye
Tolulope R. Faloye
AOAtinuke Y. Odunsi
Atinuke Y. Odunsi
BOBolaji O. Oyetayo
Bolaji O. Oyetayo
Michael AschnerMichael Aschner
Michael Aschner
Alzheimer's disease (AD) is the most prevalent cause of cognitive impairment and dementia worldwide. The pathobiology of the disease has been studied in the form of several hypotheses, ranging from oxidative stress, amyloid-beta (Aβ) aggregation, accumulation of tau forming neurofibrillary tangles (NFT) through metal dysregulation and homeostasis, dysfunction of the cholinergic system, and to inflammatory and autophagic mechanism. However, none of these hypotheses has led to confirmed diagnostics or approved cure for the disease. This review is aimed as a basic and an encyclopedic short course into metals in AD and discusses the advances in chelation strategies and developments adopted in the treatment of the disease. Since there is accumulating evidence of the role of both biometal dyshomeostasis (iron (Fe), copper (Cu), and zinc (Zn)) and metal-amyloid interactions that lead to the pathogenesis of AD, this review focuses on unraveling therapeutic chelation strategies that have been considered in the treatment of the disease, aiming to sequester free and protein-bound metal ions and reducing cerebral metal burden. Promising compounds possessing chemically modified moieties evolving as multi-target ligands used as anti-AD drug candidates are also covered. Several multidirectional and multifaceted studies on metal chelation therapeutics show the need for improved synthesis, screening, and analysis of compounds to be able to effectively present chelating anti-AD drugs. Most drug candidates studied have limitations in their physicochemical properties; some enhance redistribution of metal ions, while others indirectly activate signaling pathways in AD. The metal chelation process in vivo still needs to be established and the design of potential anti-AD compounds that bi-functionally sequester metal ions as well as inhibit the Aβ aggregation by competing with the metal ions and reducing metal-induced oxidative damage and neurotoxicity may signal a bright end in chelation-based therapeutics of AD.

1 May 2017 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
AAAmos O. Abolaji
Amos O. Abolaji
MOMercy Ojo
Mercy Ojo
TATosin T. Afolabi
Tosin T. Afolabi
MAMary D. Arowoogun
Mary D. Arowoogun
DNDarlinton Nwawolor
Darlinton Nwawolor
OFOlatunde Farombi
Olatunde Farombi

1 September 2018 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
AAAmos O. Abolaji
Amos O. Abolaji
AAAdeola O. Adedara
Adeola O. Adedara
MAMojisola A. Adie
Mojisola A. Adie
MVMarta Vicente-Crespo
Marta Vicente-Crespo
EFEbenezer O. Farombi
Ebenezer O. Farombi

1 June 2014 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
AAAmos Olalekan Abolaji
Amos Olalekan Abolaji
JKJean Paul Kamdem
Jean Paul Kamdem
TLThiago Henrique Lugokenski
Thiago Henrique Lugokenski
TNThallita Kalar Nascimento
Thallita Kalar Nascimento
EWEmily Pansera Waczuk
Emily Pansera Waczuk
João RochaJoão Rocha
João Rocha

1 January 2020 in Toxicology Reports
Verified
Journal Article
Open access
AAAmos O. Abolaji
Amos O. Abolaji
KFKehinde D. Fasae
Kehinde D. Fasae
CIChizim E. Iwezor
Chizim E. Iwezor
MAMichael Aschner
Michael Aschner
EFEbenezer O. Farombi
Ebenezer O. Farombi
Curcumin is a hydrophobic polyphenol derived from the rhizome of the Herb Curcuma longa belonging to the family Zingiberaceae. Curcumin possesses antioxidative, anti-inflammatory and anti-depressant-like properties. In this study, we evaluated the rescue role of Curcumin in Copper2+-induced toxicity in D. melanogaster. Adult, wild type flies were exposed to Cu2+ (1 mM) and/or Curcumin (0.2 and 0.5 mg/kg diet) in the diet for 7 days. The results indicated that Cu2+- fed flies had reduced survival compared to the control group. Copper toxicity was also associated with a marked decrease in total thiol (T-SH), as well as catalase and glutathione S-transferase activities, contemporaneous with increased acetylcholinesterase (AChE) activity, nitric oxide (nitrate and nitrite) and dopamine levels. Co-exposure of flies to Cu2+ and Curcumin prevented mortality, inhibited AChE activity and restored dopamine to normal levels (p < 0.05). Moreover, Curcumin restored eclosion rates, and the cellular antioxidant status, as well as alleviated the accumulation of nitric oxide level in the flies. Curcumin ameliorated oxidative damage in the flies as evidenced by the survival rates, longevity assay as well as the restoration of antioxidant status. Our findings thus suggest that Curcumin ameliorated Cu2+-induced neurotoxicity in D. melanogaster and as such could be considered an effective therapeutic agent in the prevention and treatment of disorders, where oxidative stress is implicated.

15 February 2016 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
IAIsaac Adedara
Isaac Adedara
AAAmos O. Abolaji
Amos O. Abolaji
João RochaJoão Rocha
João Rocha
EFEbenezer O. Farombi
Ebenezer O. Farombi